Alvesco now available for asthma treatment

Alvesco approved for asthma
Alvesco approved for asthma
Sepracor has launched Alvesco (ciclesonide) inhalation aerosol for the prophylactic and maintenance treatment of asthma in patients ≥12 years of age. Alvesco is a lung-activated corticosteroid prodrug available in dosage strengths of 80mcg/inh and 160mcg/inh.

For more information call (800) 739-0565 or visit www.alvesco.us.

Click here to see the full Alvesco HFA new product monograph